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Abstract
Iron is essential for the oxidative metabolism of lipids. Lipid metabolism
changes during gestation to meet the requirements of the growing fetus and
to prepare for lactation. The temporal effects of iron deficiency during gesta-
tion were studied in female rats fed complete or iron-deficient diets. Plasma
triglycerides were elevated in the iron-deficient group throughout gestation.
There were time-dependent changes in the triglyceride content of the maternal
liver, falling at the midpoint of gestation and then increasing on d21.5. Com-
pared to the control, triglycerides in the maternal liver were not different in
the iron-deficient group prior to pregnancy and on d12.5, but were markedly
reduced by d21.5. The abundance of mRNAs in the maternal liver suggests
that lipogenesis is unchanged and beta-oxidation is reduced on d21.5 by iron
deficiency. On d21.5 of gestation, the expression of placental lipase was
unchanged by iron deficiency, however, the abundance of mRNAs for SREBP-
1c, FABP4 were reduced, suggesting that there were changes in fatty acid han-
dling. In the fetal liver, iron deficiency produced a marked decrease in the
abundance of the L-CPT-1 mRNA, suggesting that beta-oxidation is reduced.
This study shows that the major effect of iron deficiency on maternal lipid
metabolism occurs late in gestation and that perturbed lipid metabolism may
be a common feature of models of fetal programming.
Introduction
Maternal iron deficiency during pregnancy is associated
with a range of adverse outcomes in the offspring. Animal
studies have shown that the offspring of dams with low
iron status have elevated blood pressure (Gambling et al.
2003), altered metabolism (Lewis et al. 2002; Gambling
et al. 2003), and poor cognitive and behavioral develop-
ment (Tran et al. 2012). However, the underlying mecha-
nisms remain elusive. About 0.2–0.5% of the body’s iron
is found in the active sites of the physiologically essential
enzymes of oxidative metabolism, including the
cytochromes and iron-sulfur complexes of the mitochon-
dria (Dallman 1986). It is proposed that during iron defi-
ciency, the electron-carrying capacity of these enzymes is
reduced (Mackler et al. 1984; Evans and Mackler 1985)
promoting the use of glucose as the metabolic substrate
in place of lipids (Borel et al. 1993; Davis et al. 2012).
Changes in lipid metabolism and the expression of associ-
ated genes have also been reported in the fetal liver when
pregnant rats were fed iron-deficient diets (Lewis et al.
2001; Zhang et al. 2005). Changes in lipid metabolism or
the supply of fatty acids to the developing fetus have also
been reported in other models of fetal programming such
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as high fat (Williams et al. 2014) or folate-deficient diets
(McNeil et al. 2008), suggesting that lipid metabolism
may also be involved in the programming mechanism
associated with iron deficiency.
The maternal liver has a central role in regulating the
lipid supply to the feto-placental unit. Fatty acids taken
up from the gut or released from maternal adipose stores,
together with fatty acids produced by de novo synthesis,
are processed by the liver and secreted into the peripheral
circulation as lipoproteins (Cetin et al. 2009). The pool
of triglycerides within the maternal liver reflects the bal-
ance between the uptake of fatty acids, de novo lipogene-
sis, beta-oxidation, and lipoprotein secretion. Lipids
accumulate in the livers of iron-deficient adults (Ahmed
et al. 2012), suggesting that one or more of these pro-
cesses is sensitive to iron status. In other well-studied
models of nutrition development interactions, such as the
methionine-choline-deficient diet, intrahepatic lipid accu-
mulation is accompanied by a decrease in the abundance
of the mRNA for acyl CoA carboxylase-1 (Acc1) and an
increase in the abundance of the mRNA for liver-type
carnitine palmitoyl transferase-1 (L-CPT-1), as well as
corresponding changes in mRNAs for transcriptional
regulators such as peroxisome proliferator-activating
receptors (PPAR-a and -c) and sterol response element-
binding proteins (SREBP-1c) (McNeil et al. 2008). The
beta-oxidation of lipids is tightly controlled by the inter-
play between peroxisomes and mitochondria. The biogen-
esis of mitochondria and the expression of nuclear
encoded mitochondrial genes is tightly regulated by the
transcriptional activators PPAR-gamma-coactivator-1
alpha and -beta (PGC-1a and PGC-1b) and the mito-
chondrial transcription factor A (TFAM) (Archer 2013).
One of the aims of this study was to investigate the
effects of iron deficiency on the intrahepatic triglyceride
pool of the maternal liver and the expression of genes
coding for enzymes associated with lipid metabolism
during gestation.
The fetus derives its fatty acids from the peripheral cir-
culation. Free fatty acids from the maternal plasma,
together with those released from lipoproteins by placen-
tal lipase action, are taken up by fatty acid transporters in
the placenta (Duttaroy 2009). The availability of fatty
acids in the maternal circulation may therefore regulate
placental transport and metabolism via transcription fac-
tors including PPAR-a, PPAR-c, and SREBP-1c within
the placenta (Duttaroy 2006). As prepregnancy iron defi-
ciency modifies lipid concentrations, gestational iron defi-
ciency may produce changes in the abundance of key
mRNAs associated with placental lipid transporters and
function. Finally, we have also studied the abundance of
mRNAs associated with lipid metabolism in the fetal
liver.
Methods
Animals
All experimental procedures were approved by the ethical
review committee of the Rowett Research Institute and
conducted in accordance with the UK Animals (Scientific
Procedures) Act, 1986. Animals used in this study have
been described previously (Gambling et al. 2009). Briefly,
weanling rats were fed control diets for 2 weeks prior to
being randomly allocated into two groups. The animals,
with a mean body weight of 91.6  8.5 g, were fed
semisynthetic diets containing 20% w/w dried egg albu-
min, 7.5% w/w groundnut oil, with FeSO4 providing
either 50 mg Fe/kg diet (control) or 7.5 mg Fe/kg diet
(FeDef) as described previously (Gambling et al. 2003).
After feeding the experimental diets for 4 weeks, the ani-
mals (weighing 212.6  10.8 g [control] and
204.3  14.8 g [FeDef]) were mated with normal males
and then continued to be fed the same experimental diets
until d0.5, d12.5, or d21.5 of gestation, when dams were
fasted for 8 h, anesthetized with isoflurane and blood
samples were taken from the heart before the animals
were killed by cervical dislocation. Tissues were rapidly
removed, frozen in liquid nitrogen, and stored at 80°C
until required.
qRT-PCR
Frozen tissue samples (30 mg) were crushed before DNase
treated total RNA was isolated using the Qiagen RNeasy mini
kit (Qiagen, Manchester UK) following the manufacturer’s
instructions. The RNA was checked for integrity and quanti-
fied using an Agilent 2100Bioanalyser (Agilent Technologies,
Stockport, Cheshire, UK). Samples of 200 ng total RNA with
an RNA integrity number >8 were reverse transcribed with
the TaqMan Reverse Transcription Reagents Kit (Applied
Biosystems, Warrington, Cheshire, UK) primed with random
hexamers following the manufacturer’s instructions. The
products were diluted to give a final concentration equivalent
to 1 ng RNA per lL and 5 lL aliquots were used for the
PCR reactions which were carried out with either the SYBR
Green real time PCR kit with primer sequences described
previously (Lavrentyev et al. 2004; Maloney et al. 2007;
McNeil et al. 2008) or TaqMan Gene Expression Assays
(Applied Biosystems) for transcription factor A, mitochon-
drial (TFAM: Rn00580051_m1), peroxisome proliferator-
activated receptor gamma coactivator 1-beta (Ppargc 1b:
Rn00598552_m1), fatty acid transporter (Slc27a1:
Rn00585821_m1), endothelial lipase (Lipg:Rn01523950_m1),
and fatty acid-binding protein 4 (FABP4: Rn00670361_m1).
The qPCR reactions used the standard protocol provided by
the manufacturer. The abundance of cDNAs were measured
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relative to the 18S ribosomal RNA (Cat no 4319413E,
Eukaryotic 18S rRNA Endogenous Control [VIC/MGB
probe, primer limited]; Applied Biosystems) and relative tar-
get quantity was calculated from a standard curve in order to
facilitate comparisons between the SYBR Green and TaqMan
chemistries.
Triglyceride analysis
Serum triglyceride concentrations were measured using
TAG reagent (ThemoElectron Triglyceride Kit; Lab Med-
ics Ltd) with a Konelab selective chemistry analyzer (Lab-
medics Ltd, Salford, Manchester, UK).
Hepatic triglyceride concentrations were measured in
chloroform extracts as detailed previously (McNeil et al.
2008). Briefly, approximately 0.2 g tissue was homoge-
nized in 1 mL ice-cold 0.145 mol/L NaCl and extracted
with 10 mL chloroform:methanol (2:1) and the chloro-
form phase transferred to a clean tube. The aqueous
phase was washed with chloroform and, the extracts were
combined, dried and the lipids dissolved in 5 mL absolute
ethanol. Replicate 0.01 mL samples of the ethanol suspen-
sion were mixed with 0.25 mL TAG reagent, and incu-
bated for 20 min at room temperature before measuring
the absorbance at 510 nm. TAG concentrations in the
samples were determined from a standard curve.
Statistical analysis
Data are presented as mean  SEM and analyzed using
Genstat (12th/13th edition, VSN International Ltd, Hemel
Hempstead, UK). Differences between groups were
assessed by Students t-test or by two-way ANOVA with
gestational age and diet as factors. When the effects were
significant, means were compared post hoc by Fisher’s
unprotected least significant difference test. Correlation
between parameters was assessed using the linear regres-
sion function of Genstat. Statistical significance was set at
P < 0.05 unless indicated otherwise.
Results
Maternal liver
The body weight of the animals was similar until d19.5 of
gestation (Control 332.0  5.3 g vs. FeDef 323.4  7.9 g;
P = 0.37), however, by d21.5 of gestation, animals in the
FeDef group were approximately 12% lighter (Control
359.3  8.2 g vs. FeDef 315.5  18.9 g; P = 0.032). The
pups at d21 of gestation were smaller in the FeDef group
(4.1  0.1 g) when compared to the control (4.8  0.1 g,
P < 0.001) (Gambling et al. 2009). The dams hematocrit,
which was not different at mating (Control 40.8  1.4% vs.
FeDef 40.2  2%), tended to be different at 12.5 days
(Control 37.0  0.4% vs. FeDef 36.0  1.0%; P = 0.068)
and was different by d21.5 of gestation (Control
35.0  0.8% vs. FeDef 27.2  0.8%; P < 0.001). The d21.5
fetal hematocrit was also lower (Control 29.0  1% vs.
FeDef 22.0  1.0%; P < 0.001). The iron content of the
maternal liver on d21.5 of gestation was also reduced from
488.5  32.7 lg/g dry weight in the control to
74.3  5.4 lg/g dry weight in the FeDef group (P < 0.001).
Fasting plasma triglyceride concentrations (Fig. 1A)
remained constant throughout gestation, but were
increased by 20–40% compared to the control at all stages
of gestation in the iron-deficient animals (diet P = 0.014).
Figure 1. Maternal plasma and liver triglyceride. (A) Plasma triglyceride (TG) concentration in female rats fed control (light bars) or iron-
deficient diets (dark bars) on different days of gestation. Data are presented as mean + SEM (n = 6). Data analyzed by two-way ANOVA
gestational age n.s., diet P = 0.014 and gestational age.diet n.s. (B) Triglyceride (TG) concentrations in maternal liver during gestation. Data are
presented as mean + SEM (n = 6). Data analyzed by two-way ANOVA gestational age P < 0.001, diet n.s. and gestational age.diet P = 0.031.
a,bBars with different letter superscripts are significantly different Fisher’s LSD test.
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Triglyceride concentrations in the intrahepatic pool of the
maternal liver (Fig. 1B) changed substantially during the
course of pregnancy (gestational age P < 0.001). In
the animals fed the complete diet, intrahepatic triglyceride
concentrations at the midpoint of gestation (d12.5) were
about half of those of animals on d0.5 of gestation but
then increased, such that by the end of gestation (d21.5),
concentrations were approximately twofold higher than at
the start. Intrahepatic triglyceride concentrations in the
iron-deficient group were not different from the controls
on either d0.5 or d12.5 of gestation. The major effect of
iron deficiency was to prevent the increase in intrahepatic
triglyceride which occurred late in gestation in the control
group. On d21.5 of gestation, concentrations of triglyc-
eride in the livers of animals in the iron-deficient group
were similar to those on d0.5 of gestation and approxi-
mately twofold less than in the control.
The relative abundances of the mRNAs associated with
fatty acid synthesis, transport, and oxidation in the
maternal liver were influenced by both iron status and
stage of gestation (Fig. 2A). The mRNA coding for Acyl-
CoA carboxylase (Acc-1) which is the rate-limiting step
in de novo lipogenesis remained constant throughout ges-
tation in the control animals. The Acc-1 mRNA on d0.5
of gestation was 1.6 times as abundant in the livers of
animals fed the Fe-deficient diet compared to the control,
however, these differences disappeared as gestation pro-
gressed (gestational age.diet interaction P = 0.030). In
contrast, on d0.5 of gestation, iron deficiency did not
change the relative quantities of the mRNA coding for
L-CPT-1, a regulator of fatty acid oxidation, whereas by
d21.5 of gestation, it was reduced by approximately 30%
in the livers of dams fed the Fe-deficient diet compared
to the control (P = 0.023 by one-way ANOVA). The
abundance of the mRNA for CD36, remained constant
throughout gestation, but was increased in the animals
fed the Fe-deficient diet compared to the controls (diet
P = 0.009).
The abundance of the mRNAs associated with genes
which regulate fatty acid synthesis and beta-oxidation
were also influenced by iron status and stage of gestation
Figure 2. Temporal changes in relative mRNA abundance of genes
associated with fat metabolism in maternal liver. Temporal changes
during gestation in the abundance of mRNAs in the liver of female
rats fed diets containing sufficient iron (light bars) or iron deficient
(dark bars). Data are presented as mean + SEM (n = 6) and
expressed in arbitrary units relative to the 18S ribosomal RNA and
normalized to the levels of the prepregnant animals fed the control
diet. *P < 0.05 and **P < 0.01 compared to control by Student’s t-
test. (A) mRNAs coding for enzymes of lipid metabolism. Data
analyzed by two-way ANOVA; Acc1 gestational age n.s., diet n.s.
and gestational age.diet P = 0.031; L-CPT1 gestational age n.s.,
diet n.s. and gestational age.diet n.s.; CD36 gestational age n.s.,
diet 0.009 and gestational age.diet n.s. (B) mRNAs coding for
transcriptional activators. Data analyzed by two-way ANOVA; PPAR-
a gestational age 0.002, diet n.s. and gestational age.diet n.s.;
PPAR-c gestational age n.s., diet n.s. and gestational age.diet
P = 0.032 and SREBP-1c gestational age n.s., diet n.s. and
gestational age.diet n.s. (n.s. = P > 0.1.). (C). mRNAs coding for
mitochondrial transcription. Data analyzed by two-way ANOVA;
TFAM gestational age P < 0.001, diet n.s. and gestational age.diet
n.s. PGC-1a gestational age n.s., diet P = 0.002 and gestational
age.diet n.s. PGC-1b gestational age n.s., diet n.s. and gestational
age.diet n.s.
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(Fig. 2B). The abundance of the mRNA coding for
PPAR-a declined by 30–40% as gestation progressed (ges-
tational age P = 0.002), however, there was no effect of
diet and no diet.gestational age interaction. The mRNA
coding for PPAR-c was unaltered as gestation progressed
but there was an interaction between stage of gestation
and diet (diet.gestational age P = 0.034). On d0.5 of ges-
tation, the relative abundance of the PPAR-c mRNA in
the iron-deficient group was approximately half that of
the controls, but by d21.5 of gestation, expression had
increased such that it was approximately 30% higher in
the iron-deficient group compared to the controls. The
abundance of the mRNA for SREBP-1c was unaffected by
either the stage of gestation or the composition of the
diet.
The temporal changes in the abundance of mRNAs
associated with the regulation of mitochondrial activity in
the maternal liver of pregnant animals are shown in Fig-
ure 2C. The expression of TFAM, the main regulator of
nuclear mitochondrial transcripts was unaffected by either
the stage of gestation or the composition of the diet. In
the control group, the abundance of the mRNA for
PPAR-gamma coactivator 1a (PGC1-a) tended to increase
as gestation progressed (time P = 0.09 by 2-way
ANOVA), whereas the abundance declined in the Fe-
deficient group, such that by d21 of gestation, there was a
marked reduction with the abundance only approximately
40% of the control group (diet P = 0.002 by two-way
ANOVA). There was no change in PPAR-gamma coacti-
vator-1b (PGC-1b), with either time or diet.
Placenta
Iron status altered the abundance of mRNAs associated
with lipid transport in the placenta on d21.5 of gestation
(Fig. 3). Compared to the controls, the mRNA coding
for FABP4 was reduced (P = 0.017) and the fatty acid
transporter CD36 tended (P = 0.057) to be lower in the
Fe-deficient animals. In contrast, the mRNAs for
endothelial lipase (Lipg) and the fatty acid transporter
SLC27a1 (FATP1) were not different. The abundance of
the mRNAs for PPAR-a and PPAR-c were unchanged,
but there was a decrease in the mRNA coding for
SREBP-1c in the iron-deficient group (P = 0.020) and
this showed a linear positive correlation with the abun-
dance of the mRNA for CD36 (R2 = 0.81). The abun-
dance of the SREBP mRNA also showed a weak negative
correlation with plasma triglyceride concentrations
(R2 = 0.27).
Fetal liver
In the fetal liver on d21.5 of gestation (Fig. 4), the abun-
dance of the mRNAs coding for Acc1 and CD36 were
similar in both diet groups, but there was a marked
reduction of approximately 50% in the mRNA coding for
L-CPT-1 in the iron-deficient group. The abundance of
the mRNAs associated with regulatory genes PPAR-a,
PPAR-c, and SREBP-1c in fetal livers were unaffected by
the iron content of the dams diet. The abundance of
TFAM, PGC1-a, and PGC1-b mRNAs in the fetal livers
Figure 3. Relative mRNA abundance in the placenta on d21.5 of
gestation. The abundance of mRNAs in the d21.5 placentae in
pregnant rats fed control (light bars) or iron-deficient (dark bars)
diets. Data are presented as mean + SEM (n = 6) and expressed in
arbitrary units relative to the 18S ribosomal RNA and normalized to
the levels of the animals fed the control diet. Data analyzed by
Students t-test, *P < 0.05. #P < 0.1
Figure 4. Relative mRNA abundance in the fetal liver on d21.5 of
gestation. The relative abundance of mRNAs in the fetal liver on
d21.5 of gestation in rats fed control (light bars) or iron-deficient
(dark bars) diets. Data are presented as mean + SEM (n = 6) and
expressed in arbitrary units relative to the 18S ribosomal RNA and
normalized to the levels of the animals fed the control diet. Data
analyzed by Students t-test, *P < 0.05.
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on d21.5 of gestation was unaffected by iron deficiency
(data not shown).
Discussion
Lipids are of fundamental importance for the developing
fetus, both as substrates for energy metabolism and as
structural components of cellular membranes. During ges-
tation, there are substantial changes in lipid turnover to
meet the additional and changing metabolic demands of
the fetus. During the first part of pregnancy, the rat is
hyperphagic, storing fat to provide a reserve which when
mobilized at the end of gestation provides fatty acids for
fetal and mammary development (Herrera 2002). The
triglyceride pool within the dams liver reflects these
changes, first declining around d12.5 as body fat accumu-
lates in the adipocytes and then increasing again on d21.5
just before birth as a consequence of a reduction in beta-
oxidation of fatty acids and an increase in fatty acid ester-
ification (Wasfi et al. 1980). This study shows that the
handling of triglyceride within the maternal liver and also
the abundance of the mRNAs regulating its metabolism
are changed by iron deficiency with the most pronounced
effects occurring in the later stages of gestation.
Around the time of conception, iron deficiency tends
to increase plasma and intrahepatic triglyceride concen-
trations and is accompanied by an increase in the abun-
dance of the Acc-1 mRNA which is associated with
lipogenesis. These findings are consistent with an increase
in the incorporation of glucose into polar lipids and sug-
gest a shift from fat to glucose as the preferred substrate
for oxidative metabolism, results which are similar to
those previously reported in the male rat (Davis et al.
2012). As gestation progresses, this modest effect of iron
deficiency continues up to the midpoint, where the data
suggest that there is no difference in either the intrahep-
atic fat pool or in the mRNAs associated with fat metabo-
lism. At this stage of gestation, the fetal tissues represent
a relatively small portion of the total body mass and
when coupled with an increase in the limited intake of
iron due to hyperphagia, it is probable that the impact on
the dam’s iron status is very limited – a suggestion sup-
ported by the modest tendency for the hematocrit to be
lower at this time point.
The effects of iron deficiency on fat metabolism in the
maternal liver are most pronounced in the latter stages of
gestation when the degree of iron deficiency, judged by
hematocrit, is also at its greatest. This is the period when
the increase in intrahepatic triglyceride concentrations
which occurs in the control animals is markedly sup-
pressed in the iron-deficient group. This reduction to
about 40% of the control values cannot be explained by a
decrease in lipogenesis, since by d21.5, Acc-1 mRNA is
present at similar levels in both control and iron-deficient
animals. Furthermore, the abundance of the L-CPT-1
mRNA is decreased (P = 0.023 by one-way ANOVA),
suggesting reduced transfer of fatty acids to the mito-
chondria. As in the mouse (Sweeney et al. 2006), there is
a decrease in the abundance of the PPAR-a mRNA as
gestation progresses, suggesting that it has a role in reduc-
ing beta-oxidation. However, the change in the abun-
dance of the PPAR-a mRNA in the iron-deficient group
is small relative to the iron-sufficient control group, sug-
gesting that it does not mediate the effects of iron defi-
ciency. The mRNA for L-CPT-1, the transcription of
which is partly dependent on PPAR-a is reduced in the
liver on d21.5, suggesting a role for PPAR-a-independent
mechanisms, for example, those involving PGC-1a (Song
et al. 2010). The absence of an effect of iron deficiency
on the abundance of the SREBP-1c mRNA suggests that
it is not a part of the response to iron deficiency. When
lipids accumulate in the maternal liver of pregnant rats
fed methyl-deficient diets (i.e., low in folic acid, choline,
and methionine), there is an increase in the abundance of
the PPAR-c mRNA (McNeil et al. 2008). This is in keep-
ing with the general observation that PPAR-c is overex-
pressed in the livers of steatotic animals and that
hepatocyte-specific PPAR-c knockouts have decreased
hepatic lipid accumulation (Moran-Salvador et al. 2011).
However, in the iron-deficient pregnant animals, PPAR-c
expression changes in the absence of changes in intrahep-
atic lipid. Before pregnancy is established, iron deficiency
decreases the abundance of the PPAR-c mRNA in the
absence of a change in intrahepatic triglyceride and on
d21.5 of gestation, the mRNA increases in abundance
despite the intrahepatic triglyceride concentration being
similar to the prepregnancy levels. This suggests that the
changes in PPAR-c expression are not a response to the
accumulation of lipid and that an alternative mechanism
is involved in iron deficiency.
Late in gestation, there is also a marked reduction in
the abundance of the mRNA coding for PGC-1a, a tran-
scriptional coactivator that along with PPAR-c regulates
pathways linked to energy homeostasis. In the liver, PGC-
1a is induced during fasting, when the use of glucose is
reduced and the b-oxidation of fatty acids is increased
(Herzig et al. 2001; Yoon et al. 2001). The fall in the
abundance of PGC-1a may be linked to the change in
L-CPT-1 abundance and reflect a reduction in beta-oxida-
tion. However, an alternative explanation may reflect the
role of PGC-1a in the regulation of heme metabolism.
PGC-1a is involved in regulating the transcription of 5-
aminolevulinate synthase, the rate-limiting enzyme in
hepatic heme biosynthesis (Handschin et al. 2005; Wu
et al. 2009). There is a striking parallel between the iron
status of animals in the deficient group, which falls only
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in the d21 maternal liver (Gambling et al. 2009), and the
expression of PGC-1a, suggesting that this may be an
important link between nutritional status and heme
biosynthesis, as suggested by the correlation on d21.5 of
gestation between PGC-1a mRNA abundance and both
hematocrit (R2 = 0.38, P = 0.021) and the iron content
of the maternal liver (R2 = 0.42, P = 0.012).
The intrahepatic lipid pool is the product of fatty acid
uptake, synthesis, oxidation, and export. Of these factors,
a reduced flow of lipids into the maternal liver, a conse-
quence of either reduced lipolysis by adipocytes or a
decrease in the uptake from the gut is a possible explana-
tion for the reduction in intrahepatic triglyceride in the
latter stages of gestation. There is evidence that iron or
transferrin stimulates lipolysis in isolated adipocytes
(Rumberger et al. 2004), although direct evidence for an
impact of deficiency is lacking. The gut may also be a
possible target as gene array studies have shown that lipid
metabolism is altered in the duodenum of iron-deficient
rats (Collins 2008) and studies in vitro have shown that
the assembly and secretion of lipoproteins by enterocytes
is dependent on the iron status (Courtois et al. 2000).
The possibility that iron deficiency may limit fatty acid
uptake, particularly the long-chain polyunsaturated fatty
acids, is worth further investigation as one of the major
adverse effects of maternal iron deficiency is cognitive
impairment of the offspring (Georgieff 2011).
The placenta which is the interface between the mater-
nal and fetal circulation, has the potential to respond to
changes in the lipid supply. For example, in the growth
restricted human fetus, there are decreases in the abun-
dance of endothelial lipase (Lipg) mRNA and increases in
lipoprotein lipase mRNA (Lpl) (Gauster et al. 2007).
Although triglyceride concentrations in the maternal
plasma are about 40% higher in the iron-deficient ani-
mals throughout gestation, the absence of any change in
the abundance of the mRNAs coding for lipase, suggests
that this route of uptake is unchanged and that lipase
activity is responsive to fetal growth as opposed to nutri-
ent limitation. As lipases may be resent in inactive forms,
it is possible that changes in mRNA levels do not reflect
the enzyme activity (Lindegaard et al. 2005). However,
the reduced abundance of the FABP4 fatty acid-binding
protein mRNA and a tendency for a similar reduction in
the CD36 mRNA, both of which code for proteins which
transport free fatty acids within the placenta, does suggest
that the supply of fatty acids may be compromised in
some way. The decrease in the abundance of SREBP-1
mRNA, with no change in PPAR-a and PPAR-c, in the
placenta of the iron-deficient animals also suggests a
change in free fatty acid turnover as it has been suggested
that placental SREBP-1 controls the expression of
enzymes responsible for the endogenous synthesis of
saturated and monounsaturated fatty acids (Weedon-Fek-
jaer et al. 2005; Duttaroy 2009). The long-chain fatty
acids produced by these enzymes are key components of
membrane phospholipids, suggesting that while the bulk
transfer of fatty acids is unaffected, iron deficiency may
have specific effects on the availability of particular fatty
acids.
With the exception of a decrease in the abundance of
L-CPT-1 mRNA, suggesting that the oxidation of fatty
acids is reduced in iron deficiency, there was no evidence
for other changes in lipid metabolism in the fetal liver.
Previous studies have shown that the expression of
SREBP-1c and its associated target genes was reduced in
the fetal liver when dams were fed an iron-deficient diet
(Zhang et al. 2005). The discrepancy between the study of
Zhang et al. and the present results may be the conse-
quence of the substantial differences in the experimental
diets; 3 mg Fe/kg diet compared to 7.5 mg Fe/kg in the
present experiment and 5.2% w/w fat compared to 10%
w/w fat in the present experiment. The impact of this
apparent interaction between iron and fat in the diet of
the pregnant animal is worthy of further investigation.
Overall, the data from the present experiment suggest that
fetal lipid metabolism is largely protected, however, the
decrease in L-CPT-1 abundance does suggest that fat oxi-
dation is reduced in the fetal liver. Carnitine, used by
L-CPT-1 for the production of acylcarnitines, is synthe-
sized by a pathway containing two iron-dependent
enzymes (Vaz and Wanders 2002). While iron deficiency
does not affect the concentration of carnitine in the liver,
there is evidence for the impaired transport of carnitine
to heart and skeletal muscle in female rats (Bartholmey
and Sherman 1986). The reduced availability of carnitine
late in gestation may be related to the reduced expression
of L-CPT-1 in the livers of both dam and fetus on d21.5
of gestation.
Perspectives and significance
This study shows that iron deficiency has an impact on
the temporal changes in lipid metabolism in the maternal
liver during gestation. The effect is most pronounced late
in gestation – a period when maternal lipid metabolism is
changing to support mammary development and prepare
for lactation. This raises the possibility that iron defi-
ciency may go on to affect the offspring via changes in
milk production. Changes in lipid metabolism during ges-
tation are not unique to iron deficiency; a number of
other well-characterized models of fetal programming are
also associated with abnormal lipid metabolism. For
example, maternal diets with imbalances in each of the
macronutrients, fat (Zhang et al. 2009), carbohydrate
(D’Alessandro et al. 2012), and protein (McNeil et al.
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
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2007), all increase triglyceride concentrations in the
maternal circulation and affect intrahepatic triglycerides.
This is also the case for micronutrient deficiencies such as
folic acid (McNeil et al. 2008; Maloney et al. 2009). These
observations suggest that perturbed lipid metabolism dur-
ing gestation may be a common mechanism through
which the maternal diet programs the offspring’s physiol-
ogy during fetal development.
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